10.1055/s-2008-1067039
The study presents a mild and efficient method for synthesizing 1,8-dioxodecahydroacridines via a three-component reaction involving a 1,3-dione, an aldehyde, and an amine, catalyzed by tris(pentafluorophenyl)borane [B(C6F5)3] under solvent-free conditions. The chemicals involved include 1,3-cyclohexanedione as the 1,3-dione, various aldehydes (such as benzaldehyde, aliphatic aldehydes, and heteroaromatic aldehydes), and different amines (like aniline and 4-fluoroaniline). The role of B(C6F5)3 is to act as a Lewis acid catalyst, facilitating the reaction to proceed at room temperature with high yields of the desired 1,8-dioxodecahydroacridines. The study highlights the advantages of this method over traditional Hantzsch reactions, such as shorter reaction times, milder conditions, and higher yields, making it a significant advancement in the synthesis of this class of compounds, which have applications in pharmaceuticals, dyes, and materials science.
10.1016/j.cclet.2010.03.016
The study focuses on the design, synthesis, and in vitro cytotoxicity evaluation of a series of quinoline-3-carbonitrile derivatives against four cancer cell lines: A549 (lung), HT-29 (colon), MDA-MB-231 (breast), and SMMC-7721 (liver). The research aimed to develop potent and selective anti-tumor agents by replacing the quinazoline scaffold of Gefitinib, an EGFR tyrosine kinase inhibitor, with a quinoline-3-carbonitrile scaffold. The synthesized compounds were tested for their cytotoxic effects using the MTT assay, and the results showed that several of these derivatives exhibited superior selective cytotoxicity against the SMMC-7721 cell line compared to Gefitinib, with compound 11g being the most potent among them. The study also provided preliminary insights into the structure-activity relationships of these compounds, suggesting their potential as anti-cancer agents. Further research on their anti-tumor activities and detailed structure-activity relationships is ongoing.